Cancer Treatment

Shares of Insys Therapeutics Inc (NASDAQ: INSY) plunged more than 18 percent on Thursday. Roddy Boyd of SIRF wrote a scathing research report on Thursday titled "Murder Incorporated: Insys Therapeutics" in which he argued the company is ‘in a great deal of trouble.'...